AGIO ▼ -0.1% - Agios Pharmaceuticals, Inc.
$AGIO reported Q3 2026 EPS of -$1.09, beating the -$1.25 estimate by 12.8%. Revenue of $55.4M beat the $50.1M estimate by 10.5%.
05-NOV-2026 06:41 AM ET
Share this post
More filings for $AGIO
AGIO ▼ -0.1% - Agios Pharmaceuticals, Inc.Nov 5, 2026AGIO ▲ +2.3% - Agios Pharmaceuticals, Inc.Nov 4, 2026AGIO ▲ +0.8% - Agios Pharmaceuticals, Inc.Oct 20, 2026$AGIO SEC Filing Update (03-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 3, 2026$AGIO SEC Filing Update (02-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 2, 2026
View full $AGIO filing history →💬 Comments
Loading comments…
Leave a comment